Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Growth

Fund Overview

Fund Size

₹158 Cr

Expense Ratio

1.04%

ISIN

INF754K01LR3

Minimum SIP

₹100

Exit Load

No Charges

Inception Date

26 Oct 2020

About this fund

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Growth is a Index Funds mutual fund schemes offered by Edelweiss Mutual Fund. This fund has been in existence for 4 years, 2 months and 27 days, having been launched on 26-Oct-20.
As of 17-Jan-25, it has a Net Asset Value (NAV) of ₹19.02, Assets Under Management (AUM) of 158.21 Crores, and an expense ratio of 1.04%.

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Growth has given a CAGR return of 16.43% since inception.
The fund's asset allocation comprises around 99.67% in equities, 0.00% in debts, and 0.33% in cash & cash equivalents.
You can start investing in Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Growth with a SIP of ₹100 or a Lumpsum investment of ₹100.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+20.23%

— (Cat Avg.)

3 Years

+14.32%

— (Cat Avg.)

Since Inception

+16.43%

— (Cat Avg.)

Portfolio Summaryas of 31st December 2024

Equity	₹157.69 Cr	99.67%
Others	₹0.52 Cr	0.33%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Sun Pharmaceuticals Industries Ltd	Equity	₹20.34 Cr	12.86%
Max Healthcare Institute Ltd Ordinary Shares	Equity	₹9.86 Cr	6.23%
Dr Reddy's Laboratories Ltd	Equity	₹9.11 Cr	5.76%
Cipla Ltd	Equity	₹9.02 Cr	5.70%
Apollo Hospitals Enterprise Ltd	Equity	₹8.25 Cr	5.22%
Divi's Laboratories Ltd	Equity	₹8.19 Cr	5.17%
Eli Lilly and Co	Equity	₹8.06 Cr	5.09%
Lupin Ltd	Equity	₹6.04 Cr	3.82%
Johnson & Johnson	Equity	₹4.5 Cr	2.84%
AbbVie Inc	Equity	₹4.05 Cr	2.56%
Fortis Healthcare Ltd	Equity	₹3.97 Cr	2.51%
Aurobindo Pharma Ltd	Equity	₹3.92 Cr	2.48%
Torrent Pharmaceuticals Ltd	Equity	₹3.83 Cr	2.42%
Novo Nordisk AS ADR	Equity	₹3.58 Cr	2.26%
Merck & Co Inc	Equity	₹3.26 Cr	2.06%
Mankind Pharma Ltd	Equity	₹3.24 Cr	2.05%
Zydus Lifesciences Ltd	Equity	₹2.75 Cr	1.74%
Ipca Laboratories Ltd	Equity	₹2.66 Cr	1.68%
Alkem Laboratories Ltd	Equity	₹2.61 Cr	1.65%
Thermo Fisher Scientific Inc	Equity	₹2.57 Cr	1.62%
Glenmark Pharmaceuticals Ltd	Equity	₹2.55 Cr	1.61%
Abbott Laboratories	Equity	₹2.54 Cr	1.61%
Novartis AG ADR	Equity	₹2.48 Cr	1.57%
Intuitive Surgical Inc	Equity	₹2.39 Cr	1.51%
Laurus Labs Ltd	Equity	₹2.37 Cr	1.50%
Danaher Corp	Equity	₹1.93 Cr	1.22%
Piramal Pharma Ltd	Equity	₹1.82 Cr	1.15%
Amgen Inc	Equity	₹1.81 Cr	1.14%
Syngene International Ltd	Equity	₹1.75 Cr	1.10%
Biocon Ltd	Equity	₹1.72 Cr	1.08%
Stryker Corp	Equity	₹1.6 Cr	1.01%
Gilead Sciences Inc	Equity	₹1.49 Cr	0.94%
Gland Pharma Ltd	Equity	₹1.48 Cr	0.94%
J.B. Chemicals & Pharmaceuticals Ltd	Equity	₹1.45 Cr	0.92%
Ajanta Pharma Ltd	Equity	₹1.44 Cr	0.91%
Vertex Pharmaceuticals Inc	Equity	₹1.34 Cr	0.85%
Medtronic PLC	Equity	₹1.32 Cr	0.84%
Suven Pharmaceuticals Ltd	Equity	₹1.3 Cr	0.82%
GlaxoSmithKline Pharmaceuticals Ltd	Equity	₹1.07 Cr	0.68%
Regeneron Pharmaceuticals Inc	Equity	₹0.99 Cr	0.63%
Global Health Ltd	Equity	₹0.98 Cr	0.62%
Becton Dickinson & Co	Equity	₹0.85 Cr	0.53%
Agilent Technologies Inc	Equity	₹0.5 Cr	0.31%
IQVIA Holdings Inc	Equity	₹0.46 Cr	0.29%
Clearing Corporation Of India Ltd.	Cash - Repurchase Agreement	₹0.36 Cr	0.23%
Illumina Inc	Equity	₹0.27 Cr	0.17%
Net Receivables/(Payables)	Cash - Collateral	₹0.16 Cr	0.10%
GRAIL Inc	Equity	₹0.01 Cr	0.00%
Accrued Interest	Cash - Collateral	₹0 Cr	0.00%

Allocation By Market Cap (Equity)

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹157.69 Cr	99.67%

Risk & Performance Ratios

Fund Managers

Bhavesh Jain

Since October 2021

Amit Vora

Since February 2021

Additional Scheme Detailsas of 31st December 2024

ISIN

INF754K01LR3

Expense Ratio

1.04%

Exit Load

No Charges

Fund Size

₹158 Cr

Age

4 years 2 months

Lumpsum Minimum

₹100

Fund Status

Open Ended Investment Company

Benchmark

MSCI Ind Dom & Wld HealthC 45 NR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Index Funds Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
ICICI Prudential Nifty Midcap 150 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹620.49 Cr	12.9%
ICICI Prudential Nifty Midcap 150 Index Fund Regular Growth Very High Risk	0.9%	0.0%	₹620.49 Cr	12.2%
ICICI Prudential Nifty 200 Momentum 30 Index Fund Regular Growth Very High Risk	1.0%	0.0%	₹502.65 Cr	4.7%
SBI Nifty Midcap 150 Index Fund Regular Growth Very High Risk	1.0%	0.0%	₹740.33 Cr	12.3%
DSP Nifty 50 Equal Weight Index Fund Regular Growth Very High Risk	0.9%	0.0%	₹1896.35 Cr	7.5%
SBI Nifty Smallcap 250 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹1301.32 Cr	13.2%
SBI Nifty Midcap 150 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹740.33 Cr	13.0%
ICICI Prudential Nifty 200 Momentum 30 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹502.65 Cr	5.3%
DSP Nifty 50 Equal Weight Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹1896.35 Cr	8.1%
SBI Nifty Smallcap 250 Index Fund Regular Growth Very High Risk	1.0%	0.0%	₹1301.32 Cr	12.5%

About the AMC

Edelweiss Mutual Fund

+91 22 40979900

https://www.edelweissmf.com/

Total AUM

₹1,62,188 Cr

Address

J.P.Morgan Tower, Mumbai, 400 098

Other Funds by Edelweiss Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Edelweiss Multi Cap Fund Direct Growth Very High Risk	0.3%	1.0%	₹2628.28 Cr	19.2%
Edelweiss Banking and PSU Debt Fund Direct Growth Moderate Risk	0.4%	0.0%	₹268.66 Cr	8.5%
Edelweiss NIFTY Large Midcap 250 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹233.32 Cr	11.1%
Edelweiss Money Market Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹1232.92 Cr	7.7%
Edelweiss Liquid Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹5489.08 Cr	7.5%
Edelweiss Mid Cap Fund Direct Growth Very High Risk	0.4%	1.0%	₹8666.49 Cr	27.6%
Edelweiss Greater China Equity Direct Growth Very High Risk	1.3%	1.0%	₹1659.13 Cr	26.0%
Edelweiss ASEAN Equity Off Shore Direct Growth Very High Risk	1.6%	1.0%	₹96.39 Cr	19.3%
Edelweiss Large & Mid Cap Fund Direct Growth Very High Risk	0.4%	1.0%	₹3796.28 Cr	16.6%
Edelweiss CRISIL PSU Plus SDL 50:50 Oct 2025 Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹807.91 Cr	7.6%
Edelweiss Europe Dynamic Equity Offshore Fund Direct Growth Very High Risk	1.5%	1.0%	₹73.57 Cr	12.9%
BHARAT Bond FOF April 2030 Direct Growth Moderate Risk	0.1%	0.0%	₹6871.21 Cr	8.7%
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Fund Direct Growth Moderate Risk	0.2%	0.0%	₹155.40 Cr	8.5%
Edelweiss Flexi Cap Fund Direct Growth Very High Risk	0.4%	1.0%	₹2468.59 Cr	18.1%
Edelweiss Overnight Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹271.44 Cr	6.6%
Edelweiss Multi Asset Allocation Fund Direct Growth Low to Moderate Risk	0.4%	0.0%	₹1436.24 Cr	8.2%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth Very High Risk	0.5%	0.0%	₹158.21 Cr	20.9%
Edelweiss Long Term Equity Fund Direct Growth Very High Risk	0.7%	0.0%	₹398.26 Cr	14.5%
Edelweiss Recently Listed IPO Fund Direct Growth Very High Risk	1.0%	2.0%	₹1010.77 Cr	19.4%
Edelweiss Balanced Advantage Fund Direct Growth Very High Risk	0.5%	1.0%	₹12428.49 Cr	11.3%
Edelweiss Government Securities Fund Direct Growth Moderate Risk	0.5%	0.0%	₹172.65 Cr	10.4%
Edelweiss Small Cap Fund Direct Growth Very High Risk	0.4%	1.0%	₹4428.21 Cr	16.9%
Edelweiss Nifty Smallcap 250 Index Fund Direct Growth Very High Risk	0.1%	0.0%	₹102.67 Cr	13.7%
Edelweiss Nifty Midcap150 Momentum 50 Index Fund Direct Growth Very High Risk	0.5%	0.0%	₹811.17 Cr	13.7%
Edelweiss Nifty Next 50 Index Fund Direct Growth Very High Risk	0.1%	0.0%	₹100.44 Cr	16.4%
Edelweiss Large Cap Fund Direct Growth Very High Risk	0.6%	1.0%	₹1109.74 Cr	12.1%
Edelweiss Aggressive Hybrid Fund Direct Growth Very High Risk	0.3%	1.0%	₹2363.37 Cr	16.5%
Edelweiss Focused Equity Fund Direct Growth Very High Risk	0.7%	1.0%	₹921.64 Cr	16.2%
Edelweiss Nifty PSU Bond Plus SDL Apr 2027 50:50 Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹2277.50 Cr	8.2%
BHARAT Bond FOF April 2025 Direct Growth Low to Moderate Risk	0.1%	0.0%	₹4173.99 Cr	7.7%
BHARAT Bond FOF April 2031 Direct Growth Moderate Risk	0.1%	0.0%	₹4675.14 Cr	9.5%
Edelweiss Arbitrage Fund Direct Growth Low Risk	0.4%	0.0%	₹12135.81 Cr	8.3%
Edelweiss Emerging Markets Opportunities Equity Offshore Direct Growth Very High Risk	1.5%	1.0%	₹114.90 Cr	14.1%
Edelweiss US Technology Equity Fund of Fund Direct Growth Very High Risk	1.5%	1.0%	₹2645.38 Cr	41.2%
BHARAT Bond ETF FOF - April 2033 Direct Growth Moderate Risk	0.1%	0.0%	₹2275.14 Cr	9.6%
Edelweiss Gold and Silver ETF Fund of Fund Direct Growth Very High Risk	0.1%	0.0%	₹194.87 Cr	25.5%
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL June 2027 Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹95.98 Cr	8.2%
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Short Duration Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹154.56 Cr	8.3%
Edelweiss Nifty 50 Index Fund Direct Growth Very High Risk	0.1%	0.0%	₹123.87 Cr	7.4%
Edelweiss Nifty 100 Quality 30 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹144.83 Cr	8.9%
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL April 2037 Index Fund Direct Growth Moderate Risk	0.2%	0.0%	₹1011.00 Cr	10.9%
BHARAT Bond ETF FOF - April 2032 Direct Growth Moderate Risk	0.1%	0.0%	₹4598.23 Cr	9.8%
Edelweiss Nifty PSU Bond Plus SDL Apr 2026 50:50 Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹7852.55 Cr	7.8%
Edelweiss US Value Equity Offshore Fund Direct Growth Very High Risk	1.4%	1.0%	₹146.72 Cr	24.1%
Edelweiss Equity Savings Fund Direct Growth Moderate Risk	0.6%	0.0%	₹561.31 Cr	12.5%

Risk Level

Your principal amount will be at Very High Risk

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

What is the current NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Growth?

The NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Growth, as of 17-Jan-2025, is ₹19.02.

What are the returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Growth?

The fund has generated 20.23% over the last 1 year and 14.32% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.

What is the portfolio composition of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Growth?

The fund's allocation of assets is distributed as 99.67% in equities, 0.00% in bonds, and 0.33% in cash and cash equivalents.

Who manages the Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Growth?

The fund managers responsible for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Growth are:-

Bhavesh Jain
Amit Vora

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

Fund Overview

Fund Size

₹158 Cr

Expense Ratio

1.04%

ISIN

INF754K01LR3

Minimum SIP

₹100

Exit Load

No Charges

Inception Date

26 Oct 2020

Risk Level

Your principal amount will be at Very High Risk